Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gates

Showing results (291-300 of 324) with videos related to

Pageof 33
Sort By:
American Journal of Surgery|February 11, 2016
Explaining the excess morbidity of emergency general surgery: packed red blood cell and fresh frozen plasma transfusion practices are associated with major complications in nonmassively transfused patientsJoaquim M Havens, Woo S Do, Haytham Kaafarani, et al.
Contraception|January 4, 2001
Two randomized controlled trials comparing the Hulka and Filshie Clips for tubal sterilizationR Dominik, D Gates, D Sokal, et al.
Cancer|August 30, 2008
Optimal dose and schedule of an HER-2/neu (E75) peptide vaccine to prevent breast cancer recurrence: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02Jarrod P Holmes, Jeremy D Gates, Linda C Benavides, et al.
Expert Review of Vaccines|February 22, 2011
Comparison of different HER2/neu vaccines in adjuvant breast cancer trials: implications for dosing of peptide vaccinesLinda C Benavides, Alan K Sears, Jeremy D Gates, et al.
Journal of Vascular Surgery|September 14, 2019
Emergency intraoperative vascular surgery consultations at a tertiary academic centerStuart L Blackwood, James J O'Leary, Rebecca E Scully, et al.
Cancer|October 13, 2011
Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02Elizabeth A Mittendorf, Guy T Clifton, Jarrod P Holmes, et al.
Human Vaccines|April 26, 2008
Monitoring circulating tumor cells in cancer vaccine trialsJ D Gates, L C Benavides, A Stojadinovic, et al.
Nanoscale|August 2, 2018
Nanoparticle localization in blood vessels: dependence on fluid shear stress, flow disturbances, and flow-induced changes in endothelial physiologyM Juliana Gomez-Garcia, Amber L Doiron, Robyn R M Steele, et al.
Shock (Augusta, Ga.)|February 10, 2015
Automated analysis of vital signs to identify patients with substantial bleeding before hospital arrival: a feasibility studyJianbo Liu, Maxim Y Khitrov, Jonathan D Gates, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
The impact of HER2/neu expression level on response to the E75 vaccine: from U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02Linda C Benavides, Jeremy D Gates, Mark G Carmichael, et al.
Pageof 33

Showing results (291-300 of 324) with videos related to

Sort By:
Pageof 33
American Journal of Surgery|February 11, 2016
Explaining the excess morbidity of emergency general surgery: packed red blood cell and fresh frozen plasma transfusion practices are associated with major complications in nonmassively transfused patientsJoaquim M Havens, Woo S Do, Haytham Kaafarani, et al.
Contraception|January 4, 2001
Two randomized controlled trials comparing the Hulka and Filshie Clips for tubal sterilizationR Dominik, D Gates, D Sokal, et al.
Cancer|August 30, 2008
Optimal dose and schedule of an HER-2/neu (E75) peptide vaccine to prevent breast cancer recurrence: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02Jarrod P Holmes, Jeremy D Gates, Linda C Benavides, et al.
Expert Review of Vaccines|February 22, 2011
Comparison of different HER2/neu vaccines in adjuvant breast cancer trials: implications for dosing of peptide vaccinesLinda C Benavides, Alan K Sears, Jeremy D Gates, et al.
Journal of Vascular Surgery|September 14, 2019
Emergency intraoperative vascular surgery consultations at a tertiary academic centerStuart L Blackwood, James J O'Leary, Rebecca E Scully, et al.
Cancer|October 13, 2011
Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02Elizabeth A Mittendorf, Guy T Clifton, Jarrod P Holmes, et al.
Human Vaccines|April 26, 2008
Monitoring circulating tumor cells in cancer vaccine trialsJ D Gates, L C Benavides, A Stojadinovic, et al.
Nanoscale|August 2, 2018
Nanoparticle localization in blood vessels: dependence on fluid shear stress, flow disturbances, and flow-induced changes in endothelial physiologyM Juliana Gomez-Garcia, Amber L Doiron, Robyn R M Steele, et al.
Shock (Augusta, Ga.)|February 10, 2015
Automated analysis of vital signs to identify patients with substantial bleeding before hospital arrival: a feasibility studyJianbo Liu, Maxim Y Khitrov, Jonathan D Gates, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
The impact of HER2/neu expression level on response to the E75 vaccine: from U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02Linda C Benavides, Jeremy D Gates, Mark G Carmichael, et al.
Pageof 33